This site is part of the Global Exhibitions Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MenaQ7® Shows Heart, Bone Health
January 18, 2012 - News

LYSAKER, Norway—Preliminary findings of a study conducted on MenaQ7® show the vitamin K2 ingredient has positive effects on several cardiovascular disease (CVD) parameters and plays positive role in bone health. According to NattoPharma, which supplies the ingredient, the three-year clinical intervention study showed MenaQ7 improved pulse wave velocity, signifying heart benefits, and better conserved bone density and quality in postmenopausal women.

NattoPharma initiated the study in 2007, and the company said it expects full results to be available later in 2012. Recruitment for the study started in early 2008 and the last measurements were completed in fall 2011. In April 2008, NattoPharma started the study with 244 postmenopausal women randomized to receive either MenaQ7® or placebo. The was conducted at VitaK at the Maastricht University in the Nederland’s and led by Associate Professor of Biochemistry Cees Vermeer. The aim of the study was to investigate the effects of a sustained intake of a low-dose (180 mcg) of natural vitamin K2 (MenaQ7) on both bone and vascular health parameters.

The compliance rate among the participants was 91.4 percent, according to the company.  

“The results from the three-year human study on MenaQ7® are encouraging," said CEO Peter Carlsson. "This is the first time in history such effects have been scientifically documented with natural vitamin K2."  He said NattoPharma will use the findings to improve its commercial platform and expand partnerships with companies commercializing MenaQ7® in the supplement and functional food markets throughout the world.

MenaQ7 provides natural vitamin K2 as a fermentation extract manufactured by using Bacillus subtilis natto. It has previously shown benefits to heart and bone health.


comments powered by Disqus
Related News
According to a published study in Epilepsia, a journal of the International League Against Epilepsy
A new study found now independent association between supplemental calcium intake and risk of
Mango consumption has been associated with healthier diets, lowered blood sugar levels in obese
New research shows KoACT increases bone strength and improves flexibility in post-menopausal women.